| Investors Business Daily | 
 enlarge | Buy New: $295.00
Avg. Customer Rating:   (based on 14 reviews)
Sales Rank: 2326
Category: Magazine
Publisher: Finadco
Studio: Finadco
Manufacturer: Finadco
Label: Finadco
Format: Newspaper Subscription
Language: English (Published)
Type: Trade magazine
Media: Magazine
Subscription Issues: 252
Subscription Length: 12 Months
Issues Per Year: 252
First Issue Lead Time: 2-4 Weeks
ASIN: B00009VPDW
Shipping: Eligible for Super Saver Shipping
Availability: Usually ships in 2 to 4 weeks
|
| Similar Items:
|
| Editorial Reviews:
Product Description
Newspaper covering companies, industries, potentially successful stocks, and developments in the economy, as well as providing analysis of national news stories.
|
| Customer Reviews: Read 9 more reviews...
 IBD does a good job July 17, 2008
When looking for info on the world of stocks and bonds the IBD is a good place to start.
 Good Stock Newspaper but very reactionary June 9, 2008
0 out of 1 found this review helpful
This is a good newspaper with TONS of financial data on individual stocks. But their recommendations are typically very reactionary and are pure momentum picks(where the stock has already appreciated substantially). Rarely are there any sort of contrarian picks or stock that have not already moved a good percentage in price.
Also, as has been mentioned before, their editorials are so right-wing that it makes for nothing more than sensational comedy.
Great paper for Investing October 29, 2007
1 out of 2 found this review helpful
This is a great paper for investors who like to do research. It is not a paper for editorial content. I found IBD's investment approach very logical. They give you all the data you need to find quality stocks. I have never read the editorials because their reputation. If I want editorial content I will go to newspapers or magazines.
Worth the Price/Ignore the Editorials if You Like April 24, 2007
6 out of 7 found this review helpful
The advice given in IBD is tremendously useful to both the novice investor and to the more seasoned investor. Following the CAN SLIM rules set forth by IBD along with the rules for investment success that IBD provides will enable you to be successful in your investment endeavors. The IBD 100 is a useful tool in which IBD ranks the top 100 stocks, based on fundamentals, etc. Obviously, the editorials prove to be controversial. If you're interested in making money and you don't agree with the views of the staff, simply don't read that page. I don't and I make money. If you want to ignore this paper simply because of its conservative viewpoints, you are probably doing yourself a great disservice. Yes, there are cheaper financial newspapers out there. The point; however, is not what you put into something--it's what you get out of it. The return on investment can be astounding if you let it.
Useful Investment Info, But Misguided Editorializing March 14, 2007
7 out of 15 found this review helpful
IBD is a useful investment tool, and Bill O'Neil's investment approach is one that a person can employ profitably.
Sadly, and as other reviewers have rightly noted, IBD's editorializing is both extreme and often seems to lack a careful analysis of the facts on any given issue (the facts being our one path to the truth).
Please, Bill O'Neil, when even conservative George Will can rightly criticize George W. Bush's foreign policy, when eminent scientists around the world state that it is 90% certain that humans are warming the planet, etc., don't stick your head in the sand and deny reality. Such positions are askew of the facts and reflect, too often, a selfish posture.
A more careful analysis of reality would lead to more tempered editorials (in most cases) and a more esteemed publication. Here's hoping that IBD moves in that direction.
|
|
|
